decision-making is HTA. He explains,
not only the assessment of the
technology but also the evaluation
and calculation of any input that goes
into the delivery of the technology
will be covered under HTA.
Narrating the story about BEMPU,
a hypothermia monitoring device,
he made a strong point that one
should practice evidence-based
approach, that stating evidence
is very important not only while
assessment of a technology but also
in day-to -day healthy lifestyle habits.
This gives context-specific inputs
into the decision-making process at
policy and organisational levels.
Evidence-based practice, Health
economic evaluation, Policy and
market analysis are the formation
bricks of the architecture of
HTA where Social aspects is also
another brick in the wall catering
its stakeholders, patients, health
professionals, industry, third party
players and the government with
trust and a good decision-making
capability. A feedback from any
stakeholder is always a good
approach to perform analysis of your
technology says Mr. John. Especially
when it comes to the customers,
patients as (here) the case is,
patient engagement is a huge buzz
topic and knowing your customer
is a great idea to improve. Taking
feedback whether they are willing
and are comfortable in using the
technology and how they feel about
the integration of it in their life could
give you the taste of your own drug.
So, what is evidence-based practice?
Evidence-based approach is the
conscientious, explicit and judicious
use of current best evidence in
making decisions about the care of
individual. Mr. John emphasizing
on the usage and reporting of the
evidence says, “wherein day-to-day
life reporting of evidence is weak,
the evidence should be taken based
on the studies from multiple trials
and research studies and not from a
single study or trial”.
After stressing on the importance
70
Volume 3 | Issue 3 | July-September 2018
brand value, potential & technical
excellence of OptiMaserTM & its
futuristic new Avatars.
for stating the evidence he also
explained the impact and need of
economic evaluation analysis which
addresses the additional health
benefit gained from investment in
a technology, such as the cost per
additional Quality Adjusted Life
Year (QALY) gained, by comparison
of that technology to a different
intervention or to no intervention.
Another important component of
this valuable session was Budget
Impact Analysis (BIA). Mr. John
told that BIA addresses the
affordability of the technology, such
as the net annual financial cost of
adopting the technology for a finite
number of years.
All this directly or indirectly
contributes to the assessment of
healthcare technology that one plans
to adopt and present. In addition to
this, he also explained briefly about
the ways a person can perform
the economic evaluation of the
technology under observation like
cost effective analysis, cost benefit
analysis or be it cost utility analysis.
Mr. John also walked listeners
through the schematic structure of
Health Technology Assessment in
India (HTAIn). Also, telling about
how patients and consumers can be
engaged in HTA, what all parameters
are there on which they can evaluate
the technology and how it would be
beneficial for the same.
Mr. Monish Bhandari said post
signing of the CITAR incubation MoU
on 2nd May 2017, the entire aura
of the association has fast tracked
with translating the lab research to
commercial success, augmenting the
OptiMaserTM potential in excess
is exemplified by the fact that it
can achieve systematic volumetric
heating for disinfection with its
mobility in any diverse industry
environment. CITAR’s clinical ability
to instantly establish protocols,
validate clinical results has given
OptiMaserTM the required thrust
to develop dedicated cycles for:
medical waste disinfection; OT
instrument disinfection; blood bag
disinfection; dialyzer disinfection;
linen disinfection; Bactec (BD) bottle
disinfection and animal bedding
(rice husk & corn cob) disinfection.
He said that the technology being
pursued by them, saves hundreds
of litres of water and electricity
consumption while disinfecting
hospital wastes - many prestigious
institutions are adopting the mode.
The IC meeting came to an end after
a very provocative question and
answer session.
Ms. Parthvee Jain is an
engineering
graduate
with
specialization and interests
in fields like Biotechnology,
Healthcare, Food Processing
and Nutraceuticals. Connecting
European Healthcare innovation
leaders
with
the
Indian
healthcare system and pioneers,
she heads the market access
program
and
partnerships
at InnovatioCuris: impacting
organizational
performance
through
expert
research,
analysis and evaluating market
competitive conditions, current
and emerging trends, and
industry-specific solutions.